Cargando…
Pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400989/ http://dx.doi.org/10.1186/2045-7022-5-S1-P4 |
| _version_ | 1782367085415890944 |
|---|---|
| author | Kordus, Katarzyna Spiewak, Radoslaw |
| author_facet | Kordus, Katarzyna Spiewak, Radoslaw |
| author_sort | Kordus, Katarzyna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4400989 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44009892015-04-29 Pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs Kordus, Katarzyna Spiewak, Radoslaw Clin Transl Allergy Poster Presentation BioMed Central 2015-03-11 /pmc/articles/PMC4400989/ http://dx.doi.org/10.1186/2045-7022-5-S1-P4 Text en Copyright © 2015 Kordus and Spiewak; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Kordus, Katarzyna Spiewak, Radoslaw Pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs |
| title | Pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs |
| title_full | Pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs |
| title_fullStr | Pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs |
| title_full_unstemmed | Pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs |
| title_short | Pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs |
| title_sort | pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400989/ http://dx.doi.org/10.1186/2045-7022-5-S1-P4 |
| work_keys_str_mv | AT korduskatarzyna pharmacotherapyofatopiceczemaananalysisofthediscrepanciesbetweenrecentexpertguidelinesofficialdruglicensesandevidenceforefficacyofrecommendeddrugs AT spiewakradoslaw pharmacotherapyofatopiceczemaananalysisofthediscrepanciesbetweenrecentexpertguidelinesofficialdruglicensesandevidenceforefficacyofrecommendeddrugs |